Full Spectrum Boswellia & Curcumin

Full Spectrum Boswellia & Curcumin

Swanson Premium Brand4.7 (1,167 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$11.09 $0.18 per serving

Product analysis

48 out of 100

Full Spectrum Boswellia & Curcumin may suit someone considering botanical support for joint comfort. The preparations are not described well enough to assume the effects of specific extracts.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The boswellia and turmeric preparations are unspecified. That matters because findings for particular extracts cannot automatically be applied to generic botanical material.

Ingredient Transparency63

The botanical amounts are disclosed, allowing quantity comparisons. Their specific forms remain unclear.

Value For Money40

The turmeric contribution is relatively costly at the full serving price. Value for boswellia remains uncertain.

Customer Satisfaction82

Buyers generally give positive feedback. A sizeable review pool adds breadth to that picture of satisfaction.

Product Focus60

The two botanicals give the formula a relatively focused joint-comfort purpose. Unclear preparations limit confidence in its likely contribution.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.18
Customer rating
4.7 · 1,167 ratings
Report analysis

Goals

Impact
Moderate effect
B+ Ingredient FitF PathwaysF EvidenceA- Formulation Logic
Boswellia · 300 mg
Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
Moderate effect
A+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Boswellia · 300 mg
Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per servingScore
Boswellia serrata
300 mg 30
Turmeric
300 mg 12
Adults 18–50
Report overview
Boswellia · 300 mg OverallScore30
F Composition And Label DisclosureC Composition And Label Disclosure
Each serving provides 300 mg of Boswellia serrata. The boswellic acid percentage is unknown. Value was not assessed.
How this ingredient is rated

Composition and Label Disclosure0

The boswellic acid percentage is unknown.
Marker and Preparation Disclosure
The boswellic acid percentage is unknown.

Composition and Label Disclosure60

The serving lists 300 mg of Boswellia serrata. The boswellic acid percentage is unknown.
Boswellia Amount and Marker Disclosure
The serving lists 300 mg of Boswellia serrata. The boswellic acid percentage is unknown.

Commercial Price and Usability

Value was not assessed.
Turmeric · 300 mg OverallScore12
F Composition And Label DisclosureF Composition And Label DisclosureD- Commercial Price And Usability
A serving provides 300 mg of turmeric at a moderate cost. The curcuminoid concentration and amount are unknown, making the turmeric contribution harder to compare.
How this ingredient is rated

Composition and Label Disclosure10

The source is turmeric, but its curcuminoid concentration is unknown.
Declared Total Curcuminoid Concentration
The source is turmeric, but its curcuminoid concentration is unknown.

Composition and Label Disclosure0

The preparation amount is stated, but the curcuminoid amount is unknown.
Preparation and Marker Amount Disclosure
The preparation amount is stated, but the curcuminoid amount is unknown.

Commercial Price and Usability40

The cost per selected serving is moderate.
Selected-Serving Price Comparison
The cost per selected serving is moderate.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsInflammation forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsInflammation forBoswellia
  3. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsInflammation forBoswellia
  4. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsInflammation Joint Health forBoswellia
  5. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsInflammation Joint Health forBoswellia
  6. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  7. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  8. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia